Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Regulatory News (HCM)

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes
Get Live Data
162.00    3.25 (2.01%)
Bid:
162.00
Ask:
167.50
Spread: 5.50 (3.395%)
Market Cap: £1.39b
HCM Live PriceLast checked at - London Stock Exchange

Intraday Hutchmed Share Chart

Blocklisting Six Monthly Return

30 Dec 2008 07:00

RNS Number : 8239K
Hutchison China Meditech Limited
30 December 2008
 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Blocklisting Six Monthly Return

Date: Tuesday, 30 December 2008: Chi-Med announces the following blocklisting six monthly return: 

1.

Name of applicant:

Hutchison China MediTech Limited

2.

Name of scheme:

Hutchison China MediTech Limited Share Option Scheme

3.

Period of return:

From 28 June 2008 to 28 December 2008

4.

Balance under scheme from previous return:

2,543,553 ordinary shares of US$1 each

5.

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return: 

Nil

6.

Number of securities issued/allotted under scheme during period:

Nil

7.

Balance under scheme not yet issued/allotted at end of the period:

2,543,553 ordinary shares of US$1 each

8.

Number and class of securities originally listed and the date of admission:

2,560,606 ordinary shares of US$1 each admitted on 26 June 2007

9.

Total number of securities in issue at the end of the period:

51,229,174 ordinary shares of US$1 each.

Name of contact:

Christian Hogg

Address of contact:

21/F., Hutchison House, 10 Harcourt RoadHong Kong

Telephone number of contact:

+852 2121 8200

Ends

Enquiries

Chi-Med

Christian Hogg, CEO

Telephone: +852 2121 8200

Citigate Dewe Rogerson

Anthony Carlisle

David Dible

Telephone: +44 (0) 20 7638 9571

+44 (0) 7973 611 888

+44 (0) 7967 566 919

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients. 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUKRARWSRUUAA
Date   Source Headline
11th May 20073:57 pmRNSResult of AGM
12th Apr 20077:00 amRNSNotice of AGM
2nd Apr 20077:04 amRNSBoard Change
23rd Mar 20077:00 amRNSDirector/PDMR Shareholding
21st Mar 200712:10 pmRNSFinal Results
26th Feb 20077:00 amRNSNotice of Results
17th Jan 20077:00 amRNSRelated Party Transaction
5th Jan 20077:53 amRNSAppointment of Joint Broker
20th Nov 20067:02 amRNSCollaboration Agreement
6th Nov 20067:01 amRNSDevelopment Agreement
29th Sep 20067:00 amRNSSenior Board Appointment
9th Aug 20067:21 amRNSInterim Results
26th Jul 200610:00 amRNSNotice of Results
17th Jul 20067:00 amRNSTrading Update
4th Jul 20067:00 amRNSClinical Update
19th May 200610:47 amRNSDirector/PDMR Shareholding
19th May 20067:01 amRNSFirst Day Trading

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.